Breast Cancer Genomics
- Cancer PHGKB -
What's New
Last Posted: Nov 21, 2018
- Clinicopathological features of breast cancer in Japanese female patients with Lynch syndrome.
Kanaya Nobuhiko et al. Breast cancer (Tokyo, Japan) 2018 Nov - Consumer and clinician perspectives on personalising breast cancer prevention information.
Keogh L A et al. Breast (Edinburgh, Scotland) 2018 Nov 4339-47 - Effect of Diets, Familial History, and Alternative Therapies on Genomic Instability of Breast Cancer Patients.
Paz Márcia Fernanda Correia Jardim et al. Applied biochemistry and biotechnology 2018 Nov - More is more: Semi-annual breast MRI screening in BRCA1 mutation carriers.
Kuhl Christiane K et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 Nov - Prevalence of pathogenic variants and variants of unknown significance in patients at high risk of breast cancer: A systematic review and meta-analysis of gene-panel data.
van Marcke C et al. Critical reviews in oncology/hematology 2018 Dec 132138-144 - Probabilistic cost-utility analysis and expected value of perfect information for the Oncotype multigenic test: a discrete event simulation model.
Ibarrondo Oliver et al. Gaceta sanitaria 2018 Nov - The identification of pathogenic variants in BRCA1/2 negative, high risk, hereditary breast and/or ovarian cancer patients: high frequency of FANCM pathogenic variants.
Schubert Stephanie et al. International journal of cancer 2018 Nov - Recent advances in breast cancer research impacting clinical diagnostic practice.
McCart Reed Amy E et al. The Journal of pathology 2018 Nov - A DNA Methylation-Based Test for Breast Cancer Detection in Circulating Cell-Free DNA.
Salta Sofia et al. Journal of clinical medicine 2018 Nov 7(11) - A Recurrent BRCA2 Mutation Explains the Majority of Hereditary Breast and Ovarian Cancer Syndrome Cases in Puerto Rico.
Diaz-Zabala Hector J et al. Cancers 2018 Nov 10(11)
.png)
No hay comentarios:
Publicar un comentario